On May 14, 2020 The Association for Accessible Medicines (AAM) filed an amicus brief in the latest constitutional challenge to the Affordable Care Act (ACA), arguing for the survival of biosimilars pathway (BPCIA), even if the individual mandate of the ACA is found unconstitutional.
Interactive Savings Map - Find out how much your state saved from generic and biosimilar medicines.